Eribulin Mesylate-related Multifocal Demyelinating Neuropathy with Myokymia in a Breast Cancer Patient

We herein report a 48-year-old woman receiving eribulin mesylate for breast cancer who presented with gait disorder, distal limb paresthesia, and weakness progressing monthly. A nerve conduction study indicated demyelination with multifocal conduction block. Considering the immune-mediated pathology...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsunogae, Marie, Fujiwara, Satoru, Shiomi, Yuma, Kikawa, Yuichiro, Kohara, Nobuo, Kawamoto, Michi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429294/
https://www.ncbi.nlm.nih.gov/pubmed/33678744
http://dx.doi.org/10.2169/internalmedicine.6780-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429294/
https://www.ncbi.nlm.nih.gov/pubmed/33678744
http://dx.doi.org/10.2169/internalmedicine.6780-20

Ejemplares similares